Attached files
| file | filename |
|---|---|
| EX-31.2 - 091231_IMX_FORM 10Q_EX 31.2 - SECURE POINT TECHNOLOGIES INC | imxform10q_091231ex31-2.htm |
| EX-32.2 - 091231_IMX_FORM 10Q_EX 32.2 - SECURE POINT TECHNOLOGIES INC | imxform10q_091231ex32-2.htm |
| EX-31.1 - 091231_IMX_FORM 10Q_EX 31.1 - SECURE POINT TECHNOLOGIES INC | imxform10q_091231ex31-1.htm |
| 10-Q - 091231_IMX_FORM 10Q - SECURE POINT TECHNOLOGIES INC | imxform10q_091231.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of Implant Sciences Corporation, a
Massachusetts corporation (the “Company”) on Form 10-Q for the period ended
December 31, 2009, as filed with the Securities and Exchange Commission on the
date hereof (the “Report”), I, Glenn D. Bolduc, President, Chief Executive
Officer and Chief Financial Officer of the Company, hereby certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to the best of my knowledge:
(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the Company.
|
/s/ Glenn D.
Bolduc
|
|
|
Glenn
D. Bolduc
|
|
|
President,
Chief Executive Officer and Chief Financial Officer
|
|
|
Date:
February 22, 2010
|
This
certification accompanies each report of we on Form 10-Q and Form 10-K pursuant
to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent
required by the Sarbanes-Oxley Act of 2002, be deemed filed by we for purposes
of §18 of the Securities Exchange Act of 1934, as amended.
A signed
original of this written statement required by §906 has been provided to us and
will be retained by us and furnished to the Securities and Exchange Commission
or our staff upon request.